Company Overview of Sucampo Pharmaceuticals, Inc.
Peter S. Greenleaf
Chairman and Chief Executive Officer, Sucampo Pharmaceuticals, Inc.
|Age||Total Calculated Compensation||This person is connected to 4 Board Members in 4 different organizations across 9 different industries.|
See Board Relationships
As of Fiscal Year 2015
805 King Farm BoulevardPhone: 301-961-3400
Rockville, Maryland 20850
Board Members Memberships
Chairman and Chief Executive Officer
Director, Member of Compensation Committee and Member of Audit Committee
Saint Joseph's University
Western Connecticut State University
|Mark R. Baker J.D.||Chief Executive Officer, Director and Member of Science Committee|
Progenics Pharmaceuticals, Inc.
|Craig A. Wheeler||Chief Executive Officer, President and Executive Director|
Momenta Pharmaceuticals Inc.
|A. J. Kazimi MBA||Founder, Chairman, Chief Executive Officer and President|
Cumberland Pharmaceuticals, Inc.
|John Anthony Sedor||Chairman, Chief Executive Officer and Member of Nominating Committee|
Pernix Therapeutics Holdings, Inc.
|Allan Oberman||Chief Executive Officer and Director|
Sagent Pharmaceuticals, Inc.
|$244.7K||Compensation as of Fiscal Year 2015.|